"Spinogenix’s Alzheimer’s drug touts disease-modifying potential in Phase IIa study" was originally created and published by ...

Research shows the p-tau217 blood test can indicate very high risk of Alzheimer's disease before symptoms begin, offering ...

Alzheimer’s disease, which represents 60–80% of dementia cases 1, robs people of their memory, cognition and independence. A decade-long period of mild cognitive impairment precedes the onset of ...